No Detail Found!

Recombinant Domain V of Beta (2)-glycoprotein I Inhibits OXLDL-induced TF Expression in Macrophages.

Author(s)
Yan Chi College of Life Science and Technology, Key Laboratory of Carbohydrate and Lipid Metabolism Research, Dalian University,
Mingying Li College of Life Science and Technology, Key Laboratory of Carbohydrate and Lipid Metabolism Research, Dalian University,
Tiantian Yu College of Life Science and Technology, Key Laboratory of Carbohydrate and Lipid Metabolism Research, Dalian University,
Jianzhong Qin College of Life Science and Technology, Key Laboratory of Carbohydrate and Lipid Metabolism Research, Dalian University,
Jingda Li College of Life Science and Technology, Key Laboratory of Carbohydrate and Lipid Metabolism Research, Dalian University,
Yuhua Chen College of Life Science and Technology, Key Laboratory of Carbohydrate and Lipid Metabolism Research, Dalian University,
Qingping Liu College of Life Science and Technology, Key Laboratory of Carbohydrate and Lipid Metabolism Research, Dalian University,
Abstract
Objective: To investigate if lectin-like oxidised low density lipoprotein receptor is implicated in oxidised low density lipoprotein induced up-regulation of tissue factor and whether recombinant domain V of beta (2)-Glycoprotein I expressed in Pichia pastoris inhibits the binding of oxidised and lectin-like low density lipoprotein. Methods: The expression of tissue factor and lectin-like oxidised low density lipoprotein receptor was detected using Western blot methods. Small interference ribonucleic acid of lectin-like oxidised low density lipoprotein receptor was used to block lectin-like oxidised low density lipoprotein receptor expression. Flow cytometry was used to test the effect of beta (2)-Glycoprotein I expressed in Pichia pastoris on the binding of oxidised low density lipoprotein with lectin-like oxidised low density lipoprotein receptor by using the lectin-like oxidised low density lipoprotein receptor-expressing 293T cells. Results: Oxidised low density lipoprotein at 5-10 mg/mL increased tissue factor and lectin-like oxidised low density lipoprotein receptor expression, whereas 20-50 mg/mL oxidised low density lipoprotein attenuated tissue factor expression. Inhibiting lectin-like oxidised low density lipoprotein receptor expression by small interference ribonucleic acid of lectin-like oxidised low density lipoprotein receptor impaired oxidised low density lipoprotein-induced tissue factor over expression in macrophages. Pretreatment with beta (2)-Glycoprotein I expressed in Pichia pastoris led to a strong inhibition of tissue factor and lectin-like oxidised low density lipoprotein receptor expression in a dose-dependent manner in macrophages. Flow cytometry analysis showed that beta (2)-Glycoprotein I expressed in Pichia pastoris attenuated the interaction of oxidised low density lipoprotein with lectin-like oxidised low density lipoprotein receptor in lectin-like oxidised low density lipoprotein receptor-expressing 293T cells. Conclusions: Lectin-like oxidised low density lipoprotein receptor was implicated in the expression of tissue factor induced by oxidised low density lipoprotein, and beta (2)-Glycoprotein I expressed in Pichia pastoris inhibited oxidised low density lipoprotein-induced tissue factor and lectin-like oxidised low density lipoprotein receptor expression, at least in part, via inhibition of the interaction between oxidised low density lipoprotein and lectin-like oxidised low density lipoprotein receptor.
Publication Details
Page(s) 1644-1649
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 11, Year: 2018

Request the full text from PASTIC

Keywords
tissue factor, Beta (2)-Glycoprotein I, Oxidised low density lipoprotein, Lectin-like oxidised LDL receptor
References
MoonsAH,LeviM,PetersRJ, 2002.Tissue factor and coronary artery disease,Cardiovascular Res 53 313 -25
CimminoG,GolinoP,BadimonJJ, 2011.Pathophysiological role of bloodborne tissue factor: should the old paradigm be revisited?,Intern Emerg Med 6 29 -34
OwensAP,MackmanN., 2011.Microparticles in hemostasis and thrombosis,Circ Res 108 1284 -97
ToschiV,GalloR,LettinoM,FallonJT,GertzSD,Fernandez-OrtizA, 1997.modulates the thrombogenicity of human atheroscl eroti c plaques,Ci rcul ation 95 594 -9
LeroyerAS,IsobeH,LesecheG,CastierY,WassefM,MallatZ, 2007.Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques,J Am Coll Cardiol 49 772 -77
PirilloA,NorataGD,CatapanoAL, 2013.LOX-1, OxLDL, and atherosclerosis,Mediators Inflamm 152786 -
MeiselSR,XuXP,EdgingtonTS,CercekB,OngJ,KaulS, 2011.Dosedependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein,J Atheroscler Thromb 18 596 -603
LiP,YangY,LiuM, 2011.Xuezhikang, extract of red yeast rice, inhibited tissue factor and hypercoagulable state through suppressing nicotinamide adenine dinucleotide phosphate oxidase and extracellular signal-regulated kinase activation,J Cardiovasc Pharmacol 58 307 -18
HongDP,HagiharaY,KatoH,GotoY., 2001.Flexible loop of beta 2- glycoprotein I domain V specifically interacts with hydrophobic ligands,Biochem 40 8092 -100
MatsuuraE,InagakiJ,KasaharaH,YamamotoD,AtsumiT,KobayashiK, 2000.Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship,Int Immunol 12 1183 -92
ZhangY,LiW,ChiY,WangR,WangD,ZhangF, 2011.Recombinant domain V of beta2-glycoprotein I inhibits the formation of a 7- ketocholesteryl-9-carboxynonanoate and beta2-glycoprotein I complex,J Biochem 149 35 -42
LiJ,ChiY,LiuS,WangL,WangR,HanX,GlycoproteinI Complexes. J Clin,Immunol, 2014.Recombinant Domain V of beta2-Glycoprotein I Inhibits the Formation of Atherogenic oxLDL/beta2-, 34 669 -76
ChiY,WangL,LiuY,MaY,WangR,HanX, 2014.-ketocholesteryl-9- carboxynonanoate enhances ATP binding cassette transporter A1 expression mediated by PPARgamma in THP-1 macrophages, 234 461 -68
LiYD,YeBQ,ZhengSX,WangJT,WangJG,ChenM, 2009.NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis,J Biol Chem 284 4473 -83
RobbesynF,SalvayreR,Negre-SalvayreA, 2004.Dual role of oxidized LDL on the NF-kappaB signaling pathway,Free Radic Res 38 541 -51
RadhikaA,SudhakaranPR, 2013.Upregulation of macrophage-specific functions by oxidized LDL: lysosomal degradation-dependent and -independent pathways,Mol Cell Biochem 372 181 -90
NagyL,TontonozP,AlvarezJG,ChenH,EvansRM, 1998.Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma,Cell 93 229 -40
KugeY,KumeN,IshinoS,TakaiN,OgawaY,MukaiT, 2008.Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits,Biol Pharm Bull 31 1475 -82
GrecoTP,Conti-KellyAM,AnthonyJR,GrecoT,DoyleR,BoisenMK, 2010.Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes,Am J Clin Pathol 133 737 -43
KobayashiK,KishiM,AtsumiT,BertolacciniML,MakinoH,SakairiN, 2003.Circulating oxidized LDL forms complexes with beta2- glycoprotein I: implication as an atherogenic autoantigen,J lipid Res 44 716 -26
LopezLR,BucknerTR,HurleyBL,KobayashiK,MatsuuraE.,Y AcadSci, 2007.Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmunemediated atherosclerosis, 1109 303 -10
HasunumaY,MatsuuraE,MakitaZ,KatahiraT,NishiS,KoikeT., 1997.Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages,Clin Exper Immunol 107 569 -73
LinKY,PanJP,YangDL,HuangKT,ChangMS,DingPY,-glycoproteinI). Life,Sci, 2001.Evidence for inhibition of low density lipoprotein oxidation and cholesterol accumulation by apolipoprotein H (beta2, 69 707 -19
ChistiakovDA,OrekhovAN,BobryshevYV, 2016.LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis,Cell Physiol Biochem 38 1851 -9
0

Citations

0

Downloads

55

Views